Skip to content

Psychedelic-assisted therapy: all studies

Page 54 of 294: studies 531 to 540 of 2,936, newest first. Back to the psychedelic-assisted therapy overview

Research

Music's essential role during psychedelic therapy

June 1, 2021 Alexander Jeffrey Kahn, Florence Ierardi

Music is an essential component of psychedelic therapy. Music can help to structure the experience, elicit emotion, facilitate meaning-making, stimulate imagery, provide continuity, support peak experiences, and more. Clients who have positive experiences with music often demonstrate higher therapeutic outcomes during psychedelic therapy. Although music is ubiquitous during psychedelic therapy,...

DOI: 10.17918/00001535 (opens in new tab) Music therapy Visual arts Psychoanalysis Psychotherapist

Psychedelic-Assisted Psychotherapy

Cambridge University Press eBooks May 28, 2021 Tim Read 2 citations

In recent years there has been a resumption of research into the potential therapeutic benefits of psychedelic1 drugs such as MDMA2, psilocybin and LSD3. Clinical research suggests significant efficacy for psychiatric disorders that have traditionally been hard to treat. The evidence base has accumulated to the point that psychedelic-assisted psychotherapy appears to be moving from a fringe...

DOI: 10.1017/9781108686976.030 (opens in new tab) Psilocybin Psychotherapist Subject documents Hallucinogen +1

CE: Psychedelic-Assisted Therapy

AJN, American Journal of Nursing May 16, 2021 Andrew Penn, Caroline Dorsen, Stephanie Hope et al. 40 citations

Psychedelics are a class of psychoactive substances that were studied extensively between 1943 and 1970 as potential therapies for treating a host of mental health disorders, including addiction. Despite promising early results, U.S. psychedelic research was halted in the early 1970s with the enactment of the Controlled Substances Act. As the field of psychedelic-assisted therapy develops,...

Psychedelic Therapy: Diplomatic Re-compositions of Life/Non-life, the Living and the Dead

The Movement for Global Mental Health April 23, 2021 Harish Naraindas 1 citation

This chapter, which is an ethnography of a psychosomatic department in a German hospital, functions as a foil to the rest of the volume. It allows us to ask the following: Why is the movement for global mental health preoccupied with the Global South? Why does mental health in the Global South primarily revolve around the psycho-pharmaceutical, while psychosomatic medicine, which in the German...

Psychedelic-Assisted Psychotherapy Practices and Human Caring Science: Toward a Care-Informed Model of Treatment

Journal of Humanistic Psychology April 23, 2021 Andrew Penn, Janis Phelps, William E Rosa et al. 37 citations

Psychedelic therapies intentionally combine a caring/healing environment, psychotherapy, and psychedelic medicine as a powerful means of treating intractable conditions of depression and posttraumatic stress disorder. This article utilizes the nursing theory of human caring science, as articulated by Jean Watson, to describe the essential and fundamental human caring qualities in psychedelic...

DOI: 10.1177/00221678211011013 (opens in new tab) Psilocybin Psychotherapist Watson Openness to experience +1

Mapping an Agenda for Psychedelic-Assisted Therapy Research in Patients with Serious Illness.

Journal of Palliative Medicine April 13, 2021 Yvan Beaussant, James A. Tulsky, Benjamin Guérin et al. 34 citations

Background: With support from the Radcliffe Institute for Advanced Study at Harvard University, we convened researchers representing palliative care, psychosocial oncology, spiritual care, oncology, and psychedelic-assisted therapies. We aimed to define priorities and envision an agenda for future research on psychedelic-assisted therapies in patients with serious illness. Over two days in...

DOI: 10.1089/jpm.2020.0764 (opens in new tab) Full text (opens in new tab) Psychedelic medicine Hallucinogen therapy Mental health: well-being Psychological health +8

Efficacy and safety results from the first pivotal phase 3 randomized controlled trial of mdma-assisted psychotherapy for treatment of severe chronic PTSD

European Psychiatry April 1, 2021 B. Van der Kolk

Introduction Posttraumatic stress disorder is a prevalent mental health condition with substantial impact on daily functioning that lacks sufficient treatment options. Previous research has led to the designation of 3,4-methylenedioxymethamphetamine (MDMA) as a Breakthrough Therapy for treatment of post-traumatic stress disorder (PTSD) when administered as an adjunct to psychotherapy....

Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer

ACS Pharmacology & Translational Science March 18, 2021 Stephen Ross, Gabrielle Agin-Liebes, Sharon L. Lo et al. 133 citations

People with advanced cancer are at heightened risk of desire for hastened death (DHD), suicidal ideation (SI), and completed suicide. Loss of Meaning (LoM), a component of demoralization, can be elevated by a cancer diagnosis and predicts DHD and SI in this population. We completed a randomized controlled trial in which psilocybin-assisted psychotherapy (PAP) produced rapid and sustained...